The concern that researchers have had since first looking at the list of genetic mutations in Omicron is that it reduces the effectiveness of vaccines. They found that it was very different from the original corona toxin used to make the vaccines.

Preliminary data are now available on how our immunity can be sustained from testing using antibiotics. These stick to the surface of the corona toxin. It prevents the atoms from sticking to it.

Studies so far have shown that antibodies in the body of those who are vaccinated twice reduce the risk of infection by 20 to 40 times.

It is not easy to tell the extent to which the results of laboratory studies are practically possible. However, with less protective antibodies, Omicron became more prevalent and at risk.

It was at this time, that good news came. Experiments with the Pfizer-Bioentech vaccine have shown a dramatic increase in third-dose antibodies. Experimental results suggest that a third dose be administered against Omicron, just as the previous two doses did against the previous Govt toxin.

Professor Elinor Riley, of the university of Edinburgh, explains, "The data so far are promising. There are no clear answers yet as to how severe the Omicron infection is.

But, even if a person has been vaccinated with two doses of the vaccine or has had an infection in the past, your immune system that fought it at the onset of the infection will still be in excellent condition.

Antibiotics are an important part of the body's defence. Also, they seem to have suffered without a booster. But, beans are only one component of the vast, complex immune system.

After a person becomes infected, D-cells pay more attention to the toxin than to the antibodies. Therefore, they are easily avoided by new strains.

But to fully understand the severity of the disease caused by Omicron, it is necessary to monitor who is affected and who goes to the hospital.